EUVIMEDEUVIMED entdecken
Crossref

Large‐Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles

Jacob W Glickman, Eden David iD, Neda Shokrian, Kelly Hawkins, Ester Del Duca, Benjamin D Hu iD, Kristina Navrazhina, Britta Carroll, Arnav Mishra, Yeriel D Estrada, Giselle Singer, James G Krueger und 1 weitere

Allergy · 2026

DOI: 10.1111/all.70157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2026. Verfasst von Jacob W Glickman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Biomarkers, Proteomics, Skin Diseases, Proteome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 143 Literaturangaben. Gefördert von: Pfizer, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While significant progress has been made in understanding the molecular characteristics of inflammatory skin diseases, their systemic impact warrants further investigation. A comprehensive large‐scale study that examines systemic proteomic expression across the most common inflammatory skin diseases is currently lacking.

Methods

Serum from 38 alopecia areata/ AA , 41 atopic dermatitis/ AD , 21 psoriasis, 18 hidradenitis suppurativa/ HS , and 25 vitiligo patients was analyzed using OLINK high‐throughput multiplex assay explore panel and compared to 49 healthy‐matched controls. Differentially expressed proteins/ DEPs were defined using the criteria of fold change/| FCH | > 1.2, FDR < 0.1. Spearman analysis was also conducted to identify correlations between biomarkers and disease severity. Gene ontology of DEPs was performed using enrichr.

Results

Our results reveal both distinct and shared patterns of systemic dysregulation across the spectrum of inflammatory diseases. HS exhibited the highest level of dysregulation compared to healthy serum, followed by AA , AD , psoriasis, and vitiligo. The DEPs identified in HS showed the greatest overlap with those in psoriasis, while AA and AD also displayed significant similarity. HS and/or psoriasis primarily showed upregulation of markers belonging to T‐cell activation/migration (interleukin/ IL ‐ 2RA / CD40LG ), innate immunity ( IL ‐6/ CXCL8 / IL ‐8), Th1 ( TNF / CXCL9 / CXCL10 ), and Th17/22 ( IL ‐ 17A / IL ‐20/ CXCL1 / LCN2 ) compared to normal. AA and/or AD were characterized by upregulation of markers of general inflammation ( MMP12 ), T‐cell activation/migration ( IL ‐15/ IL ‐16), T Helper 1/Th1 ( IFNGR1 / CXCL10 ), Th2 ( IL ‐ 4R / CCL26 / CCL27 ), Th17/22 ( IL ‐19/ IL ‐20/ PI3 ) compared to controls. HS showed the largest dysregulation in cardiovascular/ CV /atherosclerosis markers ( PDGFA / SELP / MMP9 ) compared to controls (all FDR < 0.05). Spearman analysis captured multiple positive correlations between key immune markers ( IL ‐ 4R / OX40 / TNFRSF4 / IL ‐ 17A / TNF ) and respective clinical severity scores (e.g., SALT , SCORAD , IHS4 , PASI ).

Conclusions

Various inflammatory skin diseases show shared and distinct systemic protein immune activation. Overlap across conditions encourages the investigation of shared therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersProteomicsSkin DiseasesProteomeHumansFemaleMaleAdultMiddle AgedInflammationBlood Proteins

Stichwörter der Autor:innen

atopic dermatitisbioinformaticsbiomarkersclinical immunologydermatologyinflammationpersonalized medicine

Substanzen

BiomarkersProteomeBlood Proteins

Autor:innen und Institutionen

  • Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA.

ORCID-Profile: Eden David, Benjamin D Hu, Emma Guttman-Yassky

Förderung

  • Pfizer
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Glickman, J. W., David, E., Shokrian, N., Hawkins, K., Duca, E. D., Hu, B. D., Navrazhina, K., Carroll, B., Mishra, A., Estrada, Y. D., Singer, G., Krueger, J. G., & Guttman-Yassky, E. (2026). Large‐Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles. Allergy. https://doi.org/10.1111/all.70157

Vancouver

Glickman JW, David E, Shokrian N, Hawkins K, Duca ED, Hu BD, et al. Large‐Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles. Allergy. 2026. doi:10.1111/all.70157

BibTeX
@article{Glickman2026,
  author = {Glickman, Jacob W and David, Eden and Shokrian, Neda and Hawkins, Kelly and Duca, Ester Del and Hu, Benjamin D and Navrazhina, Kristina and Carroll, Britta and Mishra, Arnav and Estrada, Yeriel D and Singer, Giselle and Krueger, James G and Guttman-Yassky, Emma},
  title = {Large‐Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70157}
}
Kostenlos starten →